Endocrine Abstracts

Background: Thyroid eye disease (TED) is common among patients with Graves’ disease (GD), with an estimated prevalence of 25-58%. While radioactive iodine (RAI) therapy is effective in managing GD, there are concerns regarding the risk of TED after RAI. Therefore, studying the effects of RAI on TED is essential for improving clinical decision-making. Aim: To determine the incidence of the development or exacerbation...